Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nutr.

Sec. Clinical Nutrition

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1630126

The association of healthy eating index score and n-3 fatty acid intake with cardiovascular diseases incidence and lipid biomarkers in Alberta's Tomorrow Project cohort

Provisionally accepted
Reihane  TaheriReihane Taheri1Olivia  WeaverOlivia Weaver2Ming  YeMing Ye2Jennifer  E VenaJennifer E Vena3Jeffrey  A JohnsonJeffrey A Johnson2Donna  VineDonna Vine1Dean  EurichDean Eurich2Spencer  D ProctorSpencer D Proctor1*
  • 1Metabolic and Cardiovascular Diseases Laboratory, Division of Human Nutrition, University of Alberta, edmonton, Canada
  • 2School of Public Health, University of Alberta, edmonton, Canada
  • 3Alberta’s Tomorrow Project, CancerCare Alberta, Alberta Health Services, Calgary, Canada

The final, formatted version of the article will be published soon.

Introduction: Unhealthy diet and dyslipidemia are major risk factors for cardiovascular disease (CVD). Studies have shown an inverse association between greater n-3 fatty acid (FA) intake and reduced dyslipidemia and CVD risk. We aimed to assess the association of the healthy eating index (HEI) score and n-3 FA intake with CVD incidence and non-fasting RC in the Alberta’s Tomorrow Project (ATP) cohort. Methods: This is a prospective study on a subset of ATP study participants (n=23,248), with the mean age of 50.2 (35-69) years, 36% male and 64% female, and no history of cancer or CVD in Alberta, Canada. Dietary intake was assessed using the Canadian Diet History Questionnaire (CDHQ), from which the Canadian HEI-2005 score and total n-3 FA intake were calculated. Lipid panel markers were measured from non-fasting blood samples, and CVD was defined using the International Statistical Classification of Diseases and Related Health Problems from linked administrative health records. The Cox proportional hazard model, linear regression, and logistic regression were used to assess the association of dietary intakes with CVD incidence, and lipid biomarkers. Results: The mean follow-up was 13.9 years. For every 1 unit increase in the HEI score, the adjusted Hazard Ratio (HR) of developing CVD decreased [HR:0.98 (95% confidence interval (CI) 0.97-0.98), 0.99 (95%CI 0.98-0.99), and 0.97 (95%CI 0.97-0.98) in females, males, and total cohort, respectively (P<0.05)]. No significant association was found between absolute n-3 FA intake (g/d) with CVD incidence. However, higher relative intake (i.e. n-3 FA as proportion of energy) increased the risk of developing CVD [HR=1.42 (95%CI 1.1-1.84), P=0.006] in males. Adjusted multivariate regression in a subset (n=8,458) showed no association between n-3 FA (g/d) intake and lipid biomarkers but a significant inverse association between HEI score and non-fasting RC [coefficient: -0.006 (95%CI -0.009- -0.003) for females and -0.01 (95%CI -0.018- -0.005) for males], and TG levels [-0.01 (95%CI -0.015- -0.006) for females and -0.01 (95%CI -0.02- -0.006) for males]. Discussion: Higher overall diet quality but not n-3 FA intake was associated with a lower risk of CVD incidence and non-fasting RC.

Keywords: Cardiovacsular Disease(s), Eicosapentadienoic acid (EPA), Diet, Dyslipideamia, Healthy Eating Index (HEI), n-3 fatly acids

Received: 16 May 2025; Accepted: 26 Aug 2025.

Copyright: © 2025 Taheri, Weaver, Ye, Vena, Johnson, Vine, Eurich and Proctor. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Spencer D Proctor, Metabolic and Cardiovascular Diseases Laboratory, Division of Human Nutrition, University of Alberta, edmonton, Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.